Tarsons Products Ltd

Tarsons Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tarsons Products Ltd

₹ 390 4.50%
13 Jun - close price
tarsons.com BSE: 543399 NSE: TARSONS
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)

Website BSE NSE
  • Market Cap ₹ 2,076 Cr.
  • Current Price ₹ 390
  • High / Low ₹ 544 / 280
  • Stock P/E 48.6
  • Book Value ₹ 123
  • Dividend Yield 0.51 %
  • ROCE 8.57 %
  • ROE 6.71 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.18 times its book value
  • Company has a low return on equity of 9.91% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 6.92% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
85 69 71 61 82 63 66 62 87 65 80 76 93
41 37 39 35 43 41 41 39 53 48 57 48 56
Operating Profit 44 31 33 27 39 21 25 23 34 17 24 28 37
OPM % 52% 45% 46% 43% 48% 34% 38% 37% 39% 26% 29% 37% 40%
3 3 4 3 2 2 3 3 6 5 11 2 6
Interest 0 0 1 1 2 2 1 3 4 4 5 4 5
Depreciation 7 6 7 7 8 8 10 10 10 9 12 16 17
Profit before tax 39 27 29 22 31 13 17 14 26 9 18 10 21
Tax % 25% 26% 25% 25% 27% 25% 26% 26% 26% 26% 26% 26% 26%
29 20 21 16 23 10 13 10 19 6 13 8 16
EPS in Rs 5.54 3.82 4.03 3.03 4.29 1.80 2.41 1.89 3.53 1.21 2.43 1.43 2.96
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
179 176 229 301 283 277 314
107 107 125 148 153 174 209
Operating Profit 72 69 103 153 130 103 105
OPM % 40% 39% 45% 51% 46% 37% 34%
6 4 5 8 12 14 24
Interest 7 6 3 4 4 10 18
Depreciation 15 14 14 22 29 38 54
Profit before tax 56 53 92 135 109 69 58
Tax % 30% 24% 25% 25% 26% 26% 26%
39 41 69 101 81 51 43
EPS in Rs 2,027.06 2,108.74 3,583.25 18.92 15.17 9.63 8.03
Dividend Payout % 0% 0% 0% 0% 0% 21% 0%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 1%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 1%
3 Years: -25%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -18%
1 Year: -22%
Return on Equity
10 Years: %
5 Years: 15%
3 Years: 10%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.19 0.20 0.19 11 11 11 11
Reserves 135 197 244 479 559 610 642
65 36 34 22 111 257 231
12 15 18 33 46 76 107
Total Liabilities 212 249 296 544 726 953 991
89 92 120 189 225 252 460
CWIP 7 19 22 32 119 267 233
Investments 0 0 0 0 0 0 13
116 137 153 323 382 434 285
Total Assets 212 249 296 544 726 953 991

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
51 64 68 83 76 105 110
-34 -26 -64 -138 -179 -296 -52
-18 -14 -27 130 85 136 -54
Net Cash Flow -0 25 -23 75 -18 -55 4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 91 79 75 79 85 94 86
Inventory Days 333 365 277 478 642 528 419
Days Payable 14 44 35 75 54 42 36
Cash Conversion Cycle 409 400 317 482 672 580 469
Working Capital Days 160 149 108 165 205 179 174
ROCE % 27% 37% 35% 19% 10% 9%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31%
9.33% 9.90% 9.60% 9.16% 8.64% 7.85% 6.83% 8.16% 7.95% 8.04% 7.51% 9.53%
8.06% 8.13% 8.52% 8.45% 7.38% 3.15% 2.60% 0.17% 0.11% 0.21% 0.51% 0.30%
35.31% 34.67% 34.59% 35.09% 36.67% 41.68% 43.27% 44.36% 44.63% 44.45% 44.69% 42.89%
No. of Shareholders 1,12,2271,07,0111,07,9451,05,3041,07,4401,08,2361,07,5641,02,8661,05,33099,58696,92793,417

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls